Evidence map›Paper›PMID 40371205›Full record

ArticleAnnals of gastroenterology

Trends in admissions and outcomes of hospitalizations related to

Sheza Malik, Ese Uwagbale, Olayemi A Adeniranc, Arshia Sethi, Raseen Tariq

Abstract read
In one paragraph

Article in Annals of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Infectious disease reports · 2026
    Review
  2. Authors' reply.Annals of gastroenterology
    Article
  3. ReassessingAnnals of gastroenterology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sheza MalikDepartment of Internal Medicine, Rochester General Hospital, Rochester, New York (Sheza Malik).
Ese UwagbaleDepartment of Gastroenterology and Hepatology, Rochester General Hospital, Rochester (Ese Uwagbale).
Olayemi A AdenirancDepartment of Cardiology, Sunny Downstate, Brooklyn, New York (Olayemi A. Adeniranc).
Arshia SethiDepartment of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York (Arshia Sethi).
Raseen TariqDepartment of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota (Raseen Tariq), USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Our study was a retrospective observational analysis using the National Inpatient Sample (NIS) from 2005-2020, focusing on US adults with primary and secondary CDI diagnoses. We performed statistical analysis using SAS 9.4 and joinpoint regression models to identify trends and changes in CDI prevalence and severity, as well as patient outcomes, over the 15-year period. Results: The study analyzed 939,282 patients, 30.2% of whom had primary and 69.8% secondary CDI diagnoses. Over the study period, there was a decline in CDI prevalence from 94.8 to 78.1 per 10,000 hospitalizations. This trend showed an increase in prevalence among younger adults (18-34 years) but a notable decrease in older adults (≥85 years). Sex-related and racial/ethnic disparities were also evident. The incidence of megacolon surged from 12.9 per 10,000 hospitalizations in 2005 to 69.8 per 10,000 in 2020, a more than fivefold increase. In contrast, in-hospital mortality from CDI significantly decreased, from 1028 deaths per 10,000 CDI diagnoses in 2005 to 687 per 10,000 in 2020, a 33.1% reduction. Conclusions: Our study indicated improved management and prevention of CDI, as evidenced by the overall decrease in prevalence and mortality. However, the increase in severity markers and the variable trends across different demographic groups highlight the need for ongoing vigilance and targeted interventions.

Indexed as

Clostridioides difficileepidemiologyhospitalizationmortalityseverity

Identifiers

PMID40371205
PMCPMC12070334

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.